MALIGNANT PLEURAL MESOTHELIOMA

Clinical trials for MALIGNANT PLEURAL MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT PLEURAL MESOTHELIOMA trials appear

Sign up with your email to follow new studies for MALIGNANT PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 3 Completed 7 Terminated 1

Mesothelioma drug trial stopped early – did it work?

Disease control Terminated

This study tested whether the drug nintedanib could help people with a rare lung cancer called malignant pleural mesothelioma. Patients who had stable disease or improvement after initial chemotherapy were given either nintedanib or a placebo to see if it delayed cancer growth. T…

Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA

Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control

Last updated May 17, 2026 03:58 UTC

MALIGNANT PLEURAL MESOTHELIOMA

Get alerted when new MALIGNANT PLEURAL MESOTHELIOMA trials appear

Mesothelioma drug trial stopped early – did it work?